The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short-Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind Placebo-Controlled Study


Main idea: The multi-strain synbiotic preparation was associated with a significant improvement in symptoms in IBS-D patients and was well-tolerated. These results suggest that the use of synbiotics offers a benefit for IBS-D patients.


The purpose of the randomized double-blind placebo-controlled trial was to assess the effectiveness of synbiotic preparation containing probiotic Lactobacillus rhamnosus FloraActive™ 19070-2, Lactobacillus acidophilus DSMZ 32418, Bifidobacterium lactis DSMZ 32269, Bifidobacterium longum DSMZ 32946, Bifidobacterium bifidum DSMZ 32403, and fructooligosaccharides in adult patients with diarrhea-dominant IBS (IBS-D). The study included eighty patients with moderate and severe IBS-D who were randomized to receive synbiotics or placebo for eight weeks. Finally, a total of sixty-eight patients finished the study. The primary endpoints included the assessment of the symptoms’ severity with the IBS symptom severity scale (IBS-SSS), an improvement of IBS global symptoms with the Global Improvement Scale (IBS-GIS), and adequate relief of symptoms after four and eight weeks of therapy. Secondary endpoints, which were collected by telephone interviewers three times a week, included the assessment of individual IBS symptoms and adverse events. Synbiotic treatment in comparison to placebo significantly improved IBS-GIS and IBS-SSS score inducing a decrease in the total IBS-SSS and in domain-specific scores related to flatulence and bowel habit after four and eight weeks. Patients treated with synbiotics reported in weekly observations of a significant amelioration in a feeling of incomplete bowel movements, flatulence, pain, stool pressure, and diarrheal stools compared to those receiving placebo. There were no differences in adverse events between both groups.


Please enter your comment!
Please enter your name here